Clinical trial
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With…
NCT00389870 · University of Leeds, Other · Completed
Key facts
| NCT number | NCT00389870 |
|---|---|
| Title | Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil |
| Official title | A Randomised Clinical Trial of Treatment for Fluorouracil-Resistant Advanced Colorectal Cancer Comparing Standard Single-Agent Irinotecan Versus Irinotecan Plus Panitumumab and Versus Irinotecan Plus Ciclosporin [Panitumumab, Irinotecan & Ciclosporin in COLOrectal Cancer Therapy (PICCOLO)] |
| Lead sponsor | University of Leeds, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | panitumumab, cyclosporine, irinotecan hydrochloride |
| Enrollment | 1,198 |
| Start date | Dec 1, 2006 |
| First posted | Oct 19, 2006 |
| Last update posted | Jun 1, 2022 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: